Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Dermatology

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    February 2019
  1. MUTEBI M
    Africa rising: gendered journeys of women patients and providers.
    Lancet. 2019;393:517-518.
    PubMed     Text format    


  2. MOSE KF, Bygum A
    Chinese herbal remedy found to contain steroids and antifungals.
    Lancet. 2019;393:446.
    PubMed     Text format    


    January 2019
  3. GILHAR A, Keren A, Paus R
    JAK inhibitors and alopecia areata.
    Lancet. 2019;393:318-319.
    PubMed     Text format    


  4. POWER SP, O'Mahony D
    Diffuse large vessel giant cell arteritis found by (18)Fluorodeoxyglucose PET/CT imaging.
    Lancet. 2019;393:349.
    PubMed     Text format    


    December 2018
  5. CAMERON DA, Gelber RD, Procter M, Suter T, et al
    Concerns about cardiotoxicity in the HERA trial - Authors' reply.
    Lancet. 2018;390:2767-2768.
    PubMed     Text format    


  6. LEVY A, Chargari C, Deutsch E, Rivera S, et al
    Concerns about cardiotoxicity in the HERA trial.
    Lancet. 2018;390:2767.
    PubMed     Text format    


  7. MEASE P, Coates LC, Helliwell PS, Stanislavchuk M, et al
    Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:2367-2377.
    PubMed     Text format     Abstract available


    October 2018
  8. MAYA Y, Tashimo A, Ota M
    Persistent red and swollen eyelids.
    Lancet. 2018;392:1552.
    PubMed     Text format    


  9. COSTEDOAT-CHALUMEAU N, Houssiau FA
    Ustekinumab: a promising new drug for SLE?
    Lancet. 2018;392:1284-1286.
    PubMed     Text format    


  10. BOUSSINESQ M
    A new powerful drug to combat river blindness.
    Lancet. 2018;392:1170-1172.
    PubMed     Text format    


  11. OPOKU NO, Bakajika DK, Kanza EM, Howard H, et al
    Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
    Lancet. 2018;392:1207-1216.
    PubMed     Text format     Abstract available


    September 2018
  12. SCHADENDORF D, van Akkooi ACJ, Berking C, Griewank KG, et al
    Melanoma.
    Lancet. 2018;392:971-984.
    PubMed     Text format     Abstract available


  13. LEBWOHL B, Sanders DS, Green PH
    Coeliac disease and dermatitis herpetiformis - Authors' reply.
    Lancet. 2018;392:917.
    PubMed     Text format    


  14. RODRIGUES F, Bachmeyer C
    Coeliac disease and dermatitis herpetiformis.
    Lancet. 2018;392:916.
    PubMed     Text format    


  15. CAIO G, De Giorgio R, Volta U
    Coeliac disease and dermatitis herpetiformis.
    Lancet. 2018;392:916-917.
    PubMed     Text format    


  16. JANARTHANAN M, Rathinasamy J
    Aortic calcification in longstanding, undiagnosed Takayasu arteritis.
    Lancet. 2018;392:950.
    PubMed     Text format    


    August 2018
  17. LA PLACA M, Chessa MA
    Erythema multiforme major with swollen lips and crusted erosions.
    Lancet. 2018;392:592.
    PubMed     Text format    


  18. BURZA S, Croft SL, Boelaert M
    Leishmaniasis.
    Lancet. 2018 Aug 17. pii: S0140-6736(18)31204.
    PubMed     Text format     Abstract available


  19. WILLER H
    Breast cancer in Venezuela: back to the 20th century.
    Lancet. 2018;392:461-462.
    PubMed     Text format    


  20. CLINE A, Feldman SR
    Risankizumab for psoriasis.
    Lancet. 2018 Aug 7. pii: S0140-6736(18)31781.
    PubMed     Text format    


  21. GORDON KB, Strober B, Lebwohl M, Augustin M, et al
    Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
    Lancet. 2018 Aug 7. pii: S0140-6736(18)31713.
    PubMed     Text format     Abstract available


    July 2018
  22. WALLACE DJ, Furie RA, Tanaka Y, Kalunian KC, et al
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2018;392:222-231.
    PubMed     Text format     Abstract available


    June 2018
  23. LIU XK, Li J
    Acral lentiginous melanoma.
    Lancet. 2018;391:e21.
    PubMed     Text format    


  24. SHEIKH S, Sasieni P
    When should the errors in the UK's breast screening programme have been spotted?
    Lancet. 2018;391:2319-2320.
    PubMed     Text format    


  25. DEODHAR A, Gottlieb AB, Boehncke WH, Dong B, et al
    Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study.
    Lancet. 2018;391:2213-2224.
    PubMed     Text format     Abstract available


  26. NASH P
    Psoriatic arthritis: novel targets add to a therapeutic renaissance.
    Lancet. 2018;391:2187-2189.
    PubMed     Text format    


  27. THE LANCET
    Psoriatic arthritis: classification and holistic management.
    Lancet. 2018;391:2185.
    PubMed     Text format    


  28. VAN DEN BOSCH F, Coates L
    Clinical management of psoriatic arthritis.
    Lancet. 2018;391:2285-2294.
    PubMed     Text format     Abstract available


  29. VEALE DJ, Fearon U
    The pathogenesis of psoriatic arthritis.
    Lancet. 2018;391:2273-2284.
    PubMed     Text format     Abstract available


  30. ZOU Y, Hu W, Zheng J, Pan M, et al
    Nail infestation: an atypical presentation of typical scabies.
    Lancet. 2018;391:2272.
    PubMed     Text format    


    April 2018
  31. MITJA O, Godornes C, Houinei W, Kapa A, et al
    Re-emergence of yaws after single mass azithromycin treatment followed by targeted treatment: a longitudinal study.
    Lancet. 2018;391:1599-1607.
    PubMed     Text format     Abstract available


  32. RIEDL MA, Relan A, Harper JR, Cicardi M, et al
    C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply.
    Lancet. 2018;391:1356.
    PubMed     Text format    


  33. MULLER YD, Harr T, Dayer E, Seebach JD, et al
    C1 esterase inhibitor concentrates and attenuated androgens.
    Lancet. 2018;391:1355-1356.
    PubMed     Text format    


    February 2018
  34. SMAJS D, Pospisilova P
    Macrolide resistance in yaws.
    Lancet. 2018 Feb 7. pii: S0140-6736(18)30205.
    PubMed     Text format    


    January 2018
  35. VAIDYA JS, Bulsara M, Wenz F, Tobias JS, et al
    Targeted radiotherapy for early breast cancer.
    Lancet. 2018;391:26-27.
    PubMed     Text format    


    October 2017
  36. AERTS O, Herman A, Bruze M, Goossens A, et al
    FreeStyle Libre: contact irritation versus contact allergy.
    Lancet. 2017;390:1644.
    PubMed     Text format    


    July 2017
  37. SCHMITT AR, Wetter DA, Camilleri MJ, Khan SP, et al
    Langerhans cell histiocytosis presenting as a blueberry muffin rash.
    Lancet. 2017;390:155.
    PubMed     Text format    


    June 2017
  38. MEASE P
    New pathways of treatment for psoriatic arthritis.
    Lancet. 2017;389:2268-2270.
    PubMed     Text format    


    February 2017
  39. SPECHT JM, Davidson NE
    Optimal duration of trastuzumab for early HER2-positive breast cancer.
    Lancet. 2017 Feb 16. pii: S0140-6736(17)30322.
    PubMed     Text format    


  40. CAMERON D, Piccart-Gebhart MJ, Gelber RD, Procter M, et al
    11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.
    Lancet. 2017 Feb 16. pii: S0140-6736(16)32616.
    PubMed     Text format     Abstract available


  41. PARES A
    An appealing new agent for treating cholestatic pruritus.
    Lancet. 2017 Feb 7. pii: S0140-6736(17)30320.
    PubMed     Text format    


  42. HEGADE VS, Kendrick SF, Dobbins RL, Miller SR, et al
    Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study.
    Lancet. 2017 Feb 7. pii: S0140-6736(17)30319.
    PubMed     Text format     Abstract available


    December 2016
  43. NATSUME O, Kabashima S, Nakazato J, Yamamoto-Hanada K, et al
    Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2016 Dec 7. pii: S0140-6736(16)31418.
    PubMed     Text format     Abstract available


    November 2016
  44. HARBECK N, Gnant M
    Breast cancer.
    Lancet. 2016 Nov 16. pii: S0140-6736(16)31891.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: